Dr. Brown on the Utility of Minimally Invasive Surgery in Ovarian Cancer

Video

In Partnership With:

Jubilee Brown, MD, discusses the utility of minimally invasive surgery in ovarian cancer.

Jubilee Brown, MD, a professor and associate director of Gynecologic Oncology at Levine Cancer Institute, of Atrium Health, discusses the utility of minimally invasive surgery in ovarian cancer.

An area of focus in ovarian cancer is minimally invasive surgery; this is often utilized at the time of diagnosis, as well as in patients with early-stage disease for primary debulking and to help with staging, says Brown.

Moreover, minimally invasive surgery can also be utilized without detriment to determine whether a patient is a good candidate for primary surgery or they should receive neoadjuvant chemotherapy instead; this is where the Fagotti score should be examined, as it can be used to determine which patients are candidates for which approach, Brown concludes.

Related Videos
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Don S. Dizon, MD
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Erin K. Crane, MD, MPH
Núria Agustí Garcia, MD
Gabriella Smith, MD
Shannon N. Westin, MD, MPH, FACOG, director, Early Drug Development, clinical medical director, professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, codirector, Ovarian Cancer Moonshot Program, The University of Texas MD Anderson Cancer Center
Debra L. Richardson, MD, FACS, FACOG
Premal Thaker, MD, MS